Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
LONG-TERM SAFETY OF TOCILIZUMAB IN RA PATIENTS TREATED FOR A MEAN DURATION OF 3.7 YEARS Genovese, M., Sebba, A., Rubbert-Roth, A., Scali, J. J., Alten, R., Kremer, J. M., Pitts, L., Vernon, E., van Vollenhoven, R. F. OXFORD UNIV PRESS. 2013: 93–94
View details for Web of Science ID 000318569000261